The Growing Impact of CFOs in Biotech Innovation with Ozan Pamir

In recent years, the biotech industry has seen remarkable expansion and innovation. Alongside this growth, the role of CFOs in the sector has transformed, bringing along unique challenges and plenty of opportunities to positively impact their companies' success. Want to understand how to navigate and triumph over these challenges and opportunities? Gain insights from Ozan Pamir, a voice of experience and expertise in the field. Ozan holds the position of Chief Financial Officer at 180 Life Sciences, playing a crucial role in successfully listing the company on NASDAQ and overseeing most of its funding rounds. He possesses a rich history of helping companies in defining their corporate strategies and skillfully navigating corporate transactions, including M&A and IPOs. Ozan was a Board Member and CFO at Unify Pharmaceuticals, Chief Financial officer at Enosi Life Sciences, Professional Member Committee Member at CFA Society Toronto, and VP of Investment Banking at Echelon Wealth Partners. In this episode, we discuss: - Challenges CFOs face in biotech - What does the modern CFO profile encompass? - Key qualities CFOs seek in potential team members within biotech - How can CFOs navigate challenging economic times? Presented by Personiv https://insights.personiv.com/cfo-weekly

There are no comments yet.

Please log in to write the first comment.